Governance

Remuneration

Information on remuneration for the board of directors

The remuneration paid to board members for their work on the board of directors of the Company is resolved by the general meeting. Board members are entitled to remuneration only as resolved by the general meeting. Any additional remuneration may, however, be paid for services provided by members of the board of directors to Cinclus Pharma within their respective areas of expertise outside their mandate as board members. Such remuneration shall be market-based and regulated in a consultancy agreement approved by the board of directors.

The 2024 Annual General Meeting decided that remuneration for the work of the board and the board's committees shall be paid, for the time until the end of the next annual general meeting, as follows:

  • SEK 480,000 to the chairman of the board,

  • SEK 240,000 to each of the board's external members,

  • SEK 50,000 to the chairman of the audit committee and SEK 25,000 to each other member of the audit committee, and

  • SEK 25,000 to the chairman of the remuneration committee and SEK 12,500 to each other member of the remuneration committee.

Board remuneration shall be paid only to external board members, which refers to board members who, as a result of employment or consulting assignments, do not take part in the Company's daily operations to an extent that corresponds to more than 50 percent of a full-time job.